An anti-COVID-19 therapeutic drug developed by DRDO called drug2-deoxy-D-glucose (2-DG) has been given emergency approval by the Drug Controller General of India (DCGI) for Coronavirus patients in the country. The Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), has developed the drug, in collaboration with Dr Reddy’s Laboratories, Hyderabad.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
In 2-DG arm, significantly higher proportion of patients improved symptomatically and became free from supplemental oxygen dependence (42% vs 31%) by day-3 in comparison to SOC, indicating an early relief from oxygen therapy/dependence. The drug comes in the form of a powder in a sachet & is supposed to be dissolved in water.
Important takeaways for all competitive exams:
World Football Day observed worldwide on 25th May, and this game connects the billions of…
The Union Government of India has released the detailed guidelines for the BHAVYA Scheme. This…
UNESCO survey has recognized the Kumbhalgarh Fort as the second longest continuous intact wall in…
As US Secretary of State Marco Rubio on his official visit to India he held…
India's Gurindervir Singh became the fastest ever Indian sprinter as he clocked an incredible 10.09…
On 25th May world observes the World Thyroid Day to raise the awareness about the…